A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation
2016 ◽
Vol 35
(4)
◽
pp. S44-S45
◽
2015 ◽
Vol 34
(4)
◽
pp. S313
2011 ◽
Vol 24
(7)
◽
pp. 651-656
◽
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 40
(4)
◽
pp. S70